Ledger.Open graph →
SEC Form D · filed July 30, 2024

SEELOS THERAPEUTICS, INC

Offering
$1.1M
Sold
Exemption
Rule 506(b)
Industry
Biotechnology
Location
NEW YORK, NY
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Brian Lian · New York, NYDirectorRichard W. Pascoe · New York, NYDirectorMichael W. Golembiewski · New York, NYExecRaj Mehra · New York, NYExecMargaret W. Dalesandro · New York, NYDirectorRichard Smith · Orem, UTDirectorMichael W. Golembiewski · New York, NYExecWilliam Dorsey · Parsippany, NJExecKent Gordon · Salt Lake City, UTDirectorMargaret W. Dalesandro · New York, NYDirectorParas Malde · Camana Bay, Grand Cayman, Cayman IslandsDirectorRiyas Nooruddin · Camana Bay, Grand Cayman, Cayman IslandsDirectorMark Levine · Washington D.C., Washington, D.C.ExecSylvester O'Byrne · Dublin, IrelandDirectorMargot Lyons · Dublin, IrelandExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗